Insights

Global CDMO Reach UQUIFA operates with a European and North American presence and a strong track record of regulatory approvals (FDA, EMA, Health Canada, PMDA, etc.), implying capability to manage global small-molecule CDMO projects from pre-clinical to commercial.

APIs Portfolio Strength A sizeable API portfolio with over 150 DMFs filed and 26 COS approved suggests robust development and supply capabilities, offering potential upsell opportunities for customers seeking integrated API and finished-dose manufacturing.

Quality & Compliance Historic regulatory success across major agencies signals a dependable quality system and manufacturing reliability, appealing to potential customers with compliance-driven procurement requirements.

Active Marketing Footprint Active participation in industry events such as Chemspec Europe and CPHI Americas indicates ongoing engagement with potential clients and a pipeline for new CDMO partnerships.

Growth via Collaboration The company’s history of acquisitions and partnerships (SONEAS, Esteve assets) suggests a strategic growth posture and potential for expanded capabilities or geographic coverage that can be leveraged to target larger or more complex small-molecule programs.

Similar companies to UQUIFA

UQUIFA Tech Stack

UQUIFA uses 8 technology products and services including Joomla, WordPress, Salesforce, and more. Explore UQUIFA's tech stack below.

UQUIFA's Email Address Formats

UQUIFA uses at least 3 email formats:
UQUIFA Email FormatsExamplePercentage
FLast@uquifa.comJDoe@uquifa.com
76%
First-Last@uquifa.comJohn-Doe@uquifa.com
19%
First@uquifa.comJohn@uquifa.com
5%

Frequently Asked Questions

What is UQUIFA's phone number?

Minus sign iconPlus sign icon
You can contact UQUIFA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is UQUIFA's official website and social media links?

Minus sign iconPlus sign icon
UQUIFA's official website is uquifa.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does UQUIFA generate?

Minus sign iconPlus sign icon
As of October 2026, UQUIFA's annual revenue is estimated to be $10M - $25M.

What is UQUIFA's SIC code and NAICS code?

Minus sign iconPlus sign icon
UQUIFA's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does UQUIFA have currently?

Minus sign iconPlus sign icon
As of October 2026, UQUIFA has approximately 381 employees across 4 continents, including Europe, North America and Asia. Key team members include Chief Marketing Officer Project Manager: B. G. M., Head Of Operations, India | Head Of Global Supply Chain: K. R. and Head Of Logistics Sant Celoni: D. G. M. Explore UQUIFA's employee directory with LeadIQ.

What industry does UQUIFA belong to?

Minus sign iconPlus sign icon
UQUIFA operates in the Pharmaceutical Manufacturing industry.

What technology does UQUIFA use?

Minus sign iconPlus sign icon
UQUIFA's tech stack includes Joomla, WordPress, Salesforce, SAP, Microsoft 365, OpenAI, DocuSign and Onsen UI.

What is UQUIFA's email format?

Minus sign iconPlus sign icon
UQUIFA's email format typically follows the pattern of FLast@uquifa.com. Find more UQUIFA email formats with LeadIQ.

When was UQUIFA founded?

Minus sign iconPlus sign icon
UQUIFA was founded in 1936.
UQUIFA logo

UQUIFA

Pharmaceutical ManufacturingCatalonia, Spain201-500 Employees

Uquifa operates as a contract development and manufacturing organization for small-molecule pharmaceuticals. The company emphasizes high quality and speed, supporting clients through the full lifecycle of New Chemical Entity programs—from preclinical work to commercial manufacturing. Headquartered in the Barcelona area of Catalonia, Spain, Uquifa maintains a European and North American footprint to serve global customers. 

Its facilities have been inspected and approved by major regulatory bodies, including the US FDA, Health Canada, EMA, PMDA, Korean FDA, ANVISA, and COFEPRIS. The group maintains an API portfolio with more than 150 active DMFs filed and 26 COS approved, reflecting its depth of regulatory and development experience in small-molecule manufacturing. In 2025, Uquifa announced participation in Chemspec Europe 2025 in Cologne, underscoring ongoing engagement with the broader pharmaceutical community.

Section iconCompany Overview

Phone number
Website
uquifa.com
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1936
Employees
201-500

Section iconFunding & Financials

  • $10M - $25M

    UQUIFA's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.